UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000008668
Receipt No. R000010187
Scientific Title Phase II study of XELIRI and bevacizumab as second-line therapy in patients with metastatic colorectal cancer
Date of disclosure of the study information 2012/08/11
Last modified on 2015/02/12 11:39:30

No. Disposal Last modified on Item of update
1 Insert 2012/08/10 17:26:19
2 Update 2015/02/12 11:39:30 Organization
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Institute
Organization1
Tel1


Contact us.